NYSEARCA:IDNA

Ishares Genomics Immunology And Healthcare Etf ETF News

etoro logo Buy IDNA
*Your capital is at risk
$26.11
+0 (+0%)
At Close: Nov 17, 2025
The iShares Genomics Immunology and Healthcare ETF is invested in 49 companies involved in genomics, immunology and bioengineering. Compared with the biotechnology benchmark IBB, IDNA has value charac
Medical breakthroughs are occurring constantly, but they often get lost in the news headlines unless they directly impact our lives. I wanted to take a moment to highlight a few recent medical breakth

IDNA: Healthcare Dashboard For February

06:39am, Sunday, 18'th Feb 2024
This article provides a monthly dashboard with aggregate industry metrics in the healthcare sector. Fast facts on IDNA, a thematic and volatile biotech ETF. We conclude with 10 healthcare stocks cheap
To use a holiday analogy, I have been checking lists and checking them twice to figure out which of next year's top disruptive investment themes are likely to be nice.
Good Morning, VettaFi Voices! Disruptive innovation is a popular topic, and it encompasses everything from bitcoin and cryptocurrency to electric vehicles to artificial intelligence.
I rate IDNA a Hold due to its focus on biotech stocks with long-term growth potential in a rapidly growing healthcare industry. Despite impressive growth since its inception in 2019, IDNA has experien
Genomic revolution and pharmacogenomics have strong growth prospects that may enable the iShares Genomics Immunology and Healthcare ETF biotech portfolio to generate supernormal growth. In order to en
A decade ago, when the ROBO Global Robotics & Automation Index ETF (ROBO) launched, the U.S. thematic ETF market was nascent, with only a handful of products and minimal assets. However, at the end of
Amid the trying circumstances in the market right now, investors may be well served to target the best biotech ETFs to buy. Fundamentally, these exchange-traded funds benefit from permanent relevance.

IDNA: Healthcare Dashboard For February

03:45pm, Thursday, 16'th Feb 2023
Pharmaceuticals and biotechnology still look attractive. Healthcare providers are close to their baseline in both valuation and quality.

Will 2023 be the Year of Cathie Wood ETFs?

09:02am, Tuesday, 24'th Jan 2023
Cathie Wood, famous for the success of Ark Investment???s winning products, had faced a miserable fate in 2022.

Can Health Care Stocks Outperform Again In 2023?

06:09pm, Wednesday, 11'th Jan 2023
How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.

IDNA: Healthcare Dashboard For November

12:26pm, Wednesday, 16'th Nov 2022
The pharmaceutical and biotechnology subsector is undervalued by about 17% relative to 11-year averages. Healthcare equipment and life science tools are overvalued by about 25% regarding the same metr

BlackRock Zeros in on Themed ETFs

03:28pm, Friday, 09'th Sep 2022
The category represents a rapidly growing portion of the issuer's lineup.
Recognition that aging populations will give rise to new healthcare needs and heightened awareness of mental health issues are bringing renewed focus to neurological health. Recent advances in genomic
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE